4//SEC Filing
Sullivan Lara 4
Accession 0000950170-24-038106
CIK 0001782223other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:33 PM ET
Size
5.5 KB
Accession
0000950170-24-038106
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Stock Option (Right to Buy)
2024-03-26$3.83/sh+1,071,242$4,102,857→ 1,071,242 totalExercise: $3.83Exp: 2034-03-26→ Common Stock (1,071,242 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 26, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:33 PM ET
- Size
- 5.5 KB